Publications by authors named "Yafit Segman"

Claim this Profile
P
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.
Hovav Azuly, Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira, Yafit Segman

Infect Dis Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab.
Tal Brosh-Nissimov, Nir Ma'aravi, Daniel Leshin-Carmel, Yonatan Edel, Sharon Ben Barouch, Yafit Segman

J Microbiol Immunol Infect· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira, Ana Belkin, Yafit Segman

Cancer Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoproliferative disease detected by breast cancer screening.
Efrat Luttwak, Yafit Segman, May Saban, Odit Gutwein, Irit Avivi

J Med Screen· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[PROLONGED POST-COVID-19 ANEMIA].
Yafit Segman, Adrian Duek, Yair Goldhechet, Marina Maklovsky, Michal Chipuck

Harefuah· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigating the interference of Daratumumab with immunofixation electrophoresis. A single-center experience using Hydrashift 2/4 kit.
Adrian Duek, Emmanuel Lellouche, Sharon Ben Baruch, Reut Mashiach, Yafit Segman

Isr Med Assoc J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Irit Avivi, Chava Perry, Yafit Segman, Odelia Amit, Yaeli Bar-On

Ann Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma with Systemic Amyloidosis: Serum Free Light Chain Dimerization Analysis in the Diagnosis of an Equivocal Case of Plasma Cell Dyscrasia.
Adrian Duek, Batia Kaplan, Yafit Segman, Merav Leiba

Isr Med Assoc J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience.
Yafit Segman, Elena Ribakovsky, Abraham Avigdor, Yair Goldhecht, Vladimir Vainstein

Leuk Lymphoma· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis